Specify a stock or a cryptocurrency in the search bar to get a summary
Bachem Holding AG
BANBBachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland. Address: Hauptstrasse 144, Bubendorf, Switzerland, 4416
Analytics
WallStreet Target Price
75.47 CHFP/E ratio
45.2961Dividend Yield
0.57 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures BANB
Dividend Analytics BANB
Dividend growth over 5 years
-31 %Continuous growth
3 yearsPayout Ratio 5 years average
33 %Dividend History BANB
Stock Valuation BANB
Financials BANB
Results | 2019 | Dynamics |